Endothelin-converting enzyme-1 expression in acute and chronic liver injury in fibrogenesis

다국어 초록 (Multilingual Abstract)

Endothelin-1 (ET-1) induces contraction, proliferation, and collagen synthesis of activated hepatic stellate cells and is a potent mediator of portal hypertension. Endothelin-converting enzyme-1 (ECE-1) generates ET-1 from the inactive precursor big-endothelin-1. The cellular distribution and activity of ECE-1 in the liver is unknown. Hepatic fibrogenesis was induced in rats by CCl4 administration and secondary biliary cirrhosis after 6 weeks of complete bile duct occlusion (BDO). The tissue ET-1 and ET receptor protein levels were quantified, the ECE-1 isoform mRNAs were measured by RNase protection assay and ECE-1 activity was analyzed. ECE-1a and -b mRNA were upregulated in biliary cirrhosis and in CCl4-injured livers, whereas ECE-1c mRNA remained unchanged. ECE-1 activity was increased after BDO and peaked at 12 h after acute CCl4- intoxication. Tissue levels of ET-1, ETA- and ETB receptors were elevated 7-, 5-, and 4.6-fold in cirrhotic rats, respectively. ECE-1 activity increased following BDO and acute CCl4-intoxication. In conclusion, ECE-1a and -b RNAs are upregulated in fibrogenesis, indicating that these isoforms play a central role in ET-1 generation during fibrogenesis and portal hypertension.

참고문헌 (Reference)

1 Huang PL, "eNOS, metabolic syndrome and cardiovascular disease" 20 : 295-302, 2009

2 Nguyen A, "Working under pressure : coronary arteries and the endothelin system" 298 : R1188-R1194, 2010

3 Barman SA, "Vasoconstrictor effect of endothelin-1 on hypertensive pulmonary arterial smooth muscle involves Rho-kinase and protein kinase C" 293 : L472-L479, 2007

4 Rodriguez-Pascual F, "The profibrotic role of endothelin-1: is the door still open for the treatment of fibrotic diseases?" 118 : 156-164, 2014

5 Kocyigit I, "The association of endothelin-1 levels with renal survival in polycystic kidney disease patients" 32 : 83-91, 2018

6 Slomiany BL, "Suppression of endothelin-converting enzyme-1 during buccal mucosal ulcer healing : effect of chronic alcohol ingestion" 271 : 318-322, 2000

7 Kohan DE, "Regulation of blood pressure and salt homeostasis by endothelin" 91 : 1-77, 2011

8 Martell M, "Physiopathology of splanchnic vasodilation in portal hypertension" 2 : 208-220, 2010

9 Valdenaire O, "Organization of the gene encoding the human endothelin-converting enzyme(ECE-1)" 270 : 29794-29297, 1995

10 Santos-Laso A, "New advances in the molecular mechanisms driving biliary fibrosis and emerging molecular targets" 18 : 908-920, 2017

11 Grantham JA, "Modulation of functionally active endothelin-converting enzyme by chronic neutral endopeptidase inhibition in experimental atherosclerosis" 101 : 1976-1981, 2000

12 Mitani H, "Increases of vascular endothelin-converting enzyme activity and endothelin-1 level on atherosclerotic lesions in hyperlipidemic rabbits" 387 : 313-319, 2000

13 Nagata T, "Increased immunoreactivities against endothelin-converting enzyme-1 and monocyte chemotactic protein-1 in hepatic stellate cells of rat fibrous liver induced by thioacetamide" 38 : 161-172, 2005

14 Schweizer A, "Human endothelinconverting enzyme(ECE-1) : three isoforms with distinct subcellular localizations" 328 : 871-877, 1997

15 Muller L, "Heterodimerization of endothelin-converting enzyme-1 isoforms regulates the subcellular distribution of this metalloprotease" 278 : 545-555, 2003

16 Orzechowski HD, "Evidence of alternative promoters directing isoform-specific expression of human endothelin-converting enzyme-1 mRNA in cultured endothelial cells" 75 : 512-521, 1997

17 Kalk P, "Endothelinconverting enzyme/neutral endopeptidase inhibitor SLV338prevents hypertensive cardiac remodeling in a blood pressure-independent manner" 57 : 755-763, 2011

18 Slomiany BL, "Endothelin-1-dependent upregulation of leptin production in gastric mucosal injury by indomethacin" 13 : 455-466, 2005

19 Moody TW, "Endothelin causes transactivation of the EGFR and HER2 in non-small cell lung cancer cells" 90 : 90-99, 2017

20 Takeda Y, "Effects of chronic neutral endopeptidase inhibition in rats with cyclosporine-induced hypertension" 18 : 927-933, 2000

21 Hocher B, "Dual endothelin-converting enzyme/neutral endopeptidase blockade in rats with D-galactosamine-induced liver failure" 16 : 275-279, 2011

22 Ling L, "Comparison of endothelin receptors in normal versus cirrhotic human liver and in the liver from endothelial cell-specific ETB knockout mice" 91 : 716-722, 2012

23 Karsdal MA, "Collagen and tissue turnover as a function of age : implications for fibrosis" 64 : 103-109, 2016

24 Shimada K, "Cloning and functional expression of endothelin-converting enzyme from rat endothelial cells" 269 : 18275-18278, 1994

25 Cho JJ, "An oral endothelin-A receptor antagonist blocks collagen synthesis and deposition in advanced rat liver fibrosis" 118 : 1169-1178, 2000